CAS number：2135696-72-7 molecular formula：C19H18BrClN6O
Tarlox-TKI, the active metabolite of Tarloxotinib, is an irreversible pan- ErbB TKI (Tarlox-TKI) In Vitro Epidermal Growth Factor Receptor (EGFR, HER1) is an attractive therapeutic target for many cancer types. Tarlox-TKI is a dose-potent EGFR inhibitor. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:EGFR
| Chinese alias | 酪氨酸激酶抑制剂 | ||
| English alias | SCHEMBL11903013 | EX-A3689 | GTPL9410 | Kinase inhibitor-1 | (2E)-N-{4-[(3-bromo-4-chlorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl}-4-(dimethylamino)but-2-enamide | QBACGOWRJDBXSG-ONEGZZNKSA-N | Tarlox-TKI | RN4000E | RN-4000E | SCHEMBL11903016 | MJ8D2M76W | ||
| CAS number | 2135696-72-7 | molecular formula | C19H18BrClN6O |
| molecular weight | 461.74 g/mol | Exact mass | ≥97% |
| PSA | 83.000 Ų | logp | 3.500 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
